Hot Products
| Catalog No. | Information |
| CFN92626 | Syringol Syringol and phenol have modifying effect on NMOR formation in vivo to be similar, the effect of food on NMOR levels in blood is more important than that of the modifiers. |
| CFN92632 | Syringylpropane Standard reference |
| CFN96061 | Syzalterin Syzalterin can protect PC12 cells effectively against Abeta-induced toxicity. |
| CFN98678 | Tabersonine Tabersonine is a precursor for vincristine used in cancer chemotherapy, the biocompatibility and small size essential for permeating the blood-brain barrier make it a potential therapeutic drug candidate for treating AD. |
| CFN90596 | Taccalonolide A Taccalonolide A is the first microtubule stabilizing agent to be discovered from a plant since identification of the mechanism of action of paclitaxel and it is the first natural product steroid identified to have these cellular effects. |
| CFN90935 | Taccalonolide AJ Taccalonolide AJ is a microtubule stabilizer; it has excellent and highly persistent antitumor efficacy when administered directly to the tumor, suggesting that the lack of antitumor efficacy seen with systemic administration of AJ is likely due to its short half-life in vivo. |
| CFN90602 | Taccalonolide B Taccalonolide B displays microtubule stabilizing activity.Several taccalonolides have in vitro antitrypanosomal activity against Trypanosoma brucei brucei and EC50 values for the isolated compounds were from 0.79 ug/mL. |
| CFN99092 | Tachioside Tachioside has antiobesity, antioxidant and α-glucosidase inhibitory activities, it decreases lipid content in 3T3-L1 adipocytes by inhibiting lipogenesis, shows antiobesity activities. Tachioside can inhibit nitric oxide production in lipopolysaccharides-stimulated RAW 264.7 cells with IC50 value of 12.14 μM. |
| CFN93134 | Tacrolimus Tacrolimus versus ciclosporin are primary immunosuppression for kidney transplant recipients. |
| CFN60416 | Tadalafil |
